Catalyst Pharmaceutical
CPRX
CPRX
101 hedge funds and large institutions have $236M invested in Catalyst Pharmaceutical in 2019 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 38 increasing their positions, 19 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
25% less capital invested
Capital invested by funds: $314M → $236M (-$77.4M)
43% less call options, than puts
Call options by funds: $981K | Put options by funds: $1.71M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
101
Holding in Top 10
1
Calls
$981K
Puts
$1.71M
Top Buyers
| 1 | +$13.4M | |
| 2 | +$4.19M | |
| 3 | +$2.8M | |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.51M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$1.46M |
Top Sellers
| 1 | -$11.9M | |
| 2 | -$9.31M | |
| 3 | -$5.1M | |
| 4 |
HRCM
Hawk Ridge Capital Management
Los Angeles,
California
|
-$3.34M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$2.54M |